Table 3.
Imaging characteristics of the pseudotumors and final diagnosis
| Pseudotumor/patient | Maximum diameter (mm) | Localization | Vascular involvement | Presence of lymphadenopathy | EUS FNA/adequate sample | Surgery | Final diagnosis |
| 1 | 35 | Body | Yes | No | Normal/yes | No | CP |
| 2 | 30 | Head | No | Yes | CP/yes | No | CP |
| 3 | 20 | Head | No | No | Normal/yes | No | CP |
| 4 | 35 | Head | Yes | Yes | Inflammation/yes | Yes | CP |
| 5 | 35 | Neck | No | No | CP/yes | No | CP |
| 6 | 28 | Body | No | No | CP/yes | No | CP |
| 7 | 30 | Neck | No | Yes | Non-neoplastic cells/yes | Yes | Myofibroblastic tumor |
| 8 | 40 | Head | Yes | Yes | Normal/yes | Yes | Pancreatic cancer |
| 9 | 40 | Head | Yes | Yes | CP/yes | Yes | Pancreatic cancer |
CP: Chronic pancreatitis; EUS: Endoscopic ultrasound; FNA: Fine needle aspiration.